Global Viral Vector Purification Market Research Report 2025

Publication ID:

PB503254467

Publication Date:

March 4, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Viral Vector Purification was valued at US$ 8178 million in the year 2024 and is projected to reach a revised size of US$ 19250 million by 2031, growing at a CAGR of 13.2% during the forecast period.
Viral vector purification is a critical step in the production of gene therapy and vaccine products that utilize viral vectors. Viral vectors are vehicles used to deliver genetic material (e.g., therapeutic genes, antigens) into target cells for various applications, including gene therapy and vaccination. The purification process is necessary to isolate and concentrate the viral vectors while removing impurities and contaminants. The goal is to produce a highly purified and potent viral vector product for safe and effective use in patients.
There is a trend toward the development of automated purification processes that can handle larger volumes and improve overall efficiency. High-throughput purification methods can be crucial for meeting the increasing demand for viral vectors in clinical and commercial applications.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Purification, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Purification.
The Viral Vector Purification market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector Purification market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Purification companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Applied Biological Materials Inc.
Creative Biolabs
Bio-Rad Laboratories, Inc.
Sirion-Biotech GmbH
Merck KGaA
FUJIFILM Diosynth Biotechnologies
Batavia Biosciences B.V.
Agilent Technologies, Inc.
Addgene
IDT Biologika GmbH
ProBioGen AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.,
Waisman Biomanufacturing
Creative Biogene
Aldevron
BioVision Inc.
Segment by Type
In Vivo
In Vitro
Segment by Application
Gene Therapy
Cell Therapy
Vaccinology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector Purification company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Purification Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vivo
1.2.3 In Vitro
1.3 Market by Application
1.3.1 Global Viral Vector Purification Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Cell Therapy
1.3.4 Vaccinology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Purification Market Perspective (2020-2031)
2.2 Global Viral Vector Purification Growth Trends by Region
2.2.1 Global Viral Vector Purification Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Vector Purification Historic Market Size by Region (2020-2025)
2.2.3 Viral Vector Purification Forecasted Market Size by Region (2026-2031)
2.3 Viral Vector Purification Market Dynamics
2.3.1 Viral Vector Purification Industry Trends
2.3.2 Viral Vector Purification Market Drivers
2.3.3 Viral Vector Purification Market Challenges
2.3.4 Viral Vector Purification Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Purification Players by Revenue
3.1.1 Global Top Viral Vector Purification Players by Revenue (2020-2025)
3.1.2 Global Viral Vector Purification Revenue Market Share by Players (2020-2025)
3.2 Global Viral Vector Purification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector Purification Revenue
3.4 Global Viral Vector Purification Market Concentration Ratio
3.4.1 Global Viral Vector Purification Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Purification Revenue in 2024
3.5 Global Key Players of Viral Vector Purification Head office and Area Served
3.6 Global Key Players of Viral Vector Purification, Product and Application
3.7 Global Key Players of Viral Vector Purification, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Purification Breakdown Data by Type
4.1 Global Viral Vector Purification Historic Market Size by Type (2020-2025)
4.2 Global Viral Vector Purification Forecasted Market Size by Type (2026-2031)
5 Viral Vector Purification Breakdown Data by Application
5.1 Global Viral Vector Purification Historic Market Size by Application (2020-2025)
5.2 Global Viral Vector Purification Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Vector Purification Market Size (2020-2031)
6.2 North America Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Vector Purification Market Size by Country (2020-2025)
6.4 North America Viral Vector Purification Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Purification Market Size (2020-2031)
7.2 Europe Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Vector Purification Market Size by Country (2020-2025)
7.4 Europe Viral Vector Purification Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Purification Market Size (2020-2031)
8.2 Asia-Pacific Viral Vector Purification Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Vector Purification Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Vector Purification Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Purification Market Size (2020-2031)
9.2 Latin America Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Vector Purification Market Size by Country (2020-2025)
9.4 Latin America Viral Vector Purification Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Purification Market Size (2020-2031)
10.2 Middle East & Africa Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Vector Purification Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Vector Purification Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Applied Biological Materials Inc.
11.1.1 Applied Biological Materials Inc. Company Details
11.1.2 Applied Biological Materials Inc. Business Overview
11.1.3 Applied Biological Materials Inc. Viral Vector Purification Introduction
11.1.4 Applied Biological Materials Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.1.5 Applied Biological Materials Inc. Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Viral Vector Purification Introduction
11.2.4 Creative Biolabs Revenue in Viral Vector Purification Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Details
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Viral Vector Purification Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Sirion-Biotech GmbH
11.4.1 Sirion-Biotech GmbH Company Details
11.4.2 Sirion-Biotech GmbH Business Overview
11.4.3 Sirion-Biotech GmbH Viral Vector Purification Introduction
11.4.4 Sirion-Biotech GmbH Revenue in Viral Vector Purification Business (2020-2025)
11.4.5 Sirion-Biotech GmbH Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Viral Vector Purification Introduction
11.5.4 Merck KGaA Revenue in Viral Vector Purification Business (2020-2025)
11.5.5 Merck KGaA Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Details
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Purification Business (2020-2025)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Batavia Biosciences B.V.
11.7.1 Batavia Biosciences B.V. Company Details
11.7.2 Batavia Biosciences B.V. Business Overview
11.7.3 Batavia Biosciences B.V. Viral Vector Purification Introduction
11.7.4 Batavia Biosciences B.V. Revenue in Viral Vector Purification Business (2020-2025)
11.7.5 Batavia Biosciences B.V. Recent Development
11.8 Agilent Technologies, Inc.
11.8.1 Agilent Technologies, Inc. Company Details
11.8.2 Agilent Technologies, Inc. Business Overview
11.8.3 Agilent Technologies, Inc. Viral Vector Purification Introduction
11.8.4 Agilent Technologies, Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.8.5 Agilent Technologies, Inc. Recent Development
11.9 Addgene
11.9.1 Addgene Company Details
11.9.2 Addgene Business Overview
11.9.3 Addgene Viral Vector Purification Introduction
11.9.4 Addgene Revenue in Viral Vector Purification Business (2020-2025)
11.9.5 Addgene Recent Development
11.10 IDT Biologika GmbH
11.10.1 IDT Biologika GmbH Company Details
11.10.2 IDT Biologika GmbH Business Overview
11.10.3 IDT Biologika GmbH Viral Vector Purification Introduction
11.10.4 IDT Biologika GmbH Revenue in Viral Vector Purification Business (2020-2025)
11.10.5 IDT Biologika GmbH Recent Development
11.11 ProBioGen AG
11.11.1 ProBioGen AG Company Details
11.11.2 ProBioGen AG Business Overview
11.11.3 ProBioGen AG Viral Vector Purification Introduction
11.11.4 ProBioGen AG Revenue in Viral Vector Purification Business (2020-2025)
11.11.5 ProBioGen AG Recent Development
11.12 Takara Bio Inc.
11.12.1 Takara Bio Inc. Company Details
11.12.2 Takara Bio Inc. Business Overview
11.12.3 Takara Bio Inc. Viral Vector Purification Introduction
11.12.4 Takara Bio Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.12.5 Takara Bio Inc. Recent Development
11.13 Thermo Fisher Scientific Inc.,
11.13.1 Thermo Fisher Scientific Inc., Company Details
11.13.2 Thermo Fisher Scientific Inc., Business Overview
11.13.3 Thermo Fisher Scientific Inc., Viral Vector Purification Introduction
11.13.4 Thermo Fisher Scientific Inc., Revenue in Viral Vector Purification Business (2020-2025)
11.13.5 Thermo Fisher Scientific Inc., Recent Development
11.14 Waisman Biomanufacturing
11.14.1 Waisman Biomanufacturing Company Details
11.14.2 Waisman Biomanufacturing Business Overview
11.14.3 Waisman Biomanufacturing Viral Vector Purification Introduction
11.14.4 Waisman Biomanufacturing Revenue in Viral Vector Purification Business (2020-2025)
11.14.5 Waisman Biomanufacturing Recent Development
11.15 Creative Biogene
11.15.1 Creative Biogene Company Details
11.15.2 Creative Biogene Business Overview
11.15.3 Creative Biogene Viral Vector Purification Introduction
11.15.4 Creative Biogene Revenue in Viral Vector Purification Business (2020-2025)
11.15.5 Creative Biogene Recent Development
11.16 Aldevron
11.16.1 Aldevron Company Details
11.16.2 Aldevron Business Overview
11.16.3 Aldevron Viral Vector Purification Introduction
11.16.4 Aldevron Revenue in Viral Vector Purification Business (2020-2025)
11.16.5 Aldevron Recent Development
11.17 BioVision Inc.
11.17.1 BioVision Inc. Company Details
11.17.2 BioVision Inc. Business Overview
11.17.3 BioVision Inc. Viral Vector Purification Introduction
11.17.4 BioVision Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.17.5 BioVision Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Applied Biological Materials Inc.
Creative Biolabs
Bio-Rad Laboratories, Inc.
Sirion-Biotech GmbH
Merck KGaA
FUJIFILM Diosynth Biotechnologies
Batavia Biosciences B.V.
Agilent Technologies, Inc.
Addgene
IDT Biologika GmbH
ProBioGen AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.,
Waisman Biomanufacturing
Creative Biogene
Aldevron
BioVision Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂